A Study of Pyridostigmine in Postural Tachycardia Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Pyridostigmine in Postural Tachycardia Syndrome — Stella

Home/Postural Tachycardia Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Postural Tachycardia Syndrome trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Mayo Clinic, Rochester, Minnesota

Key details

Phase

Safety & dosing

Sponsor

Mayo Clinic

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~50 participants

Started

October 2006

Primary completion

February 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

15 Years – 55 Years

Last updated March 2026